20 May 2013
Keywords: AstraZeneca, MedImmune, Phylogica, Antimicrobila peptides, Licensing
Article | 20 August 2010
Australian drug discovery firm Phylogica (ASX: PYC, XETRA: PH7) has entered into an agreement with Anglo-Swedish drug major AstraZeneca’s ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 August 2010
19 August 2010
© 2013 thepharmaletter.com